Pawel Bialk, MS
B.S. Mercyhurst University 2010
M.S. Delaware State University
Pawel’s current focus is on the development of new technologies related to gene editing with a specific focus on mutagenic events that occur early in oncogenic progression, specifically in leukemogenesis. He received his B.S. from Mercyhurst University in 2010 and his M.S. in biology from Delaware State University, where he studied the potential of TALENs and CRISPR/Cas9 systems in conjunction with ssODNs to enhance the efficiency of specific events in the gene editing reaction.